Effects of norakin on respiratory syncytial virus in tissue culture and in mice
Affiliations
- PMID: 2569812
Item in Clipboard
Effects of norakin on respiratory syncytial virus in tissue culture and in mice
Acta Virol.
1989 Mar.
Abstract
Norakin at 1 microgram/ml inhibits the reproduction of respiratory syncytial virus (RSV) in Vero cells to 50% and at 5 micrograms/ml to 90%. The development of lung lesions in RSV-infected BALB/c mice was suppressed by 70% when the animals were treated with two doses (25 mg/kg each) of norakin, 30 min before and 4 hr post infection. (p.i.), respectively.
Similar articles
-
Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.Toxicology. 2010 Jan 31;268(1-2):25-30. doi: 10.1016/j.tox.2009.11.014. Epub 2009 Nov 18. Toxicology. 2010. PMID: 19931343
-
DSCG reduces RSV-induced illness in RSV-infected mice.J Med Virol. 2009 Feb;81(2):354-61. doi: 10.1002/jmv.21378. J Med Virol. 2009. PMID: 19107959
-
Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.Antiviral Res. 2013 Aug;99(2):188-95. doi: 10.1016/j.antiviral.2013.05.013. Epub 2013 Jun 2. Antiviral Res. 2013. PMID: 23735300
-
Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.Biochem Pharmacol. 2017 Mar 1;127:1-12. doi: 10.1016/j.bcp.2016.09.014. Epub 2016 Sep 19. Biochem Pharmacol. 2017. PMID: 27659812 Review.
-
[Laboratory problems of chemotherapy of viral infections in humans].Postepy Hig Med Dosw. 1992;46(2):133-41. Postepy Hig Med Dosw. 1992. PMID: 1470577 Review. Polish.